Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Potential Value of Candidate Genes in Patients With Non-obstructive Azoospermia. | Urology | 2022 | 35219767 | PubTator, text mining | PubMed |
| Role of ubiquitin-protein ligase UBR5 in the disassembly of mitotic checkpoint complexes. | Proc Natl Acad Sci U S A | 2022 | 35217622 | PubTator, text mining | PubMed |
| Comprehensive Transcriptome Analysis of mRNA Expression Patterns Associated With Enhanced Biological Functions in Periodontal Ligament Stem Cells Subjected to Short-Term Hypoxia Pretreatment. | Front Genet | 2022 | 35211157 | PubTator, text mining | PubMed |
| PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis. | Cell Death Dis | 2022 | 35210406 | PubTator, text mining | PubMed |
| The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells. | Cells | 2022 | 35203286 | PubTator, text mining | PubMed |
| Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses. | Toxicol Appl Pharmacol | 2022 | 35189178 | PubTator, text mining | PubMed |
| The spindle checkpoint proteins BUB1 and BUBR1: (SLiM)ming down to the basics. | Trends Biochem Sci | 2022 | 35184951 | PubTator, text mining | PubMed |
| FAM83A is a potential biomarker for breast cancer initiation. | Biomark Res | 2022 | 35183258 | PubTator, text mining | PubMed |
| MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma. | Front Oncol | 2022 | 35174083 | PubTator, text mining | PubMed |
| ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma. | Front Oncol | 2022 | 35174076 | PubTator, text mining | PubMed |
| Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. | JAMA Netw Open | 2022 | 35171259 | PubTator, text mining | PubMed |
| Recruitment of two Ndc80 complexes via the CENP-T pathway is sufficient for kinetochore functions. | Nat Commun | 2022 | 35165266 | PubTator, text mining | PubMed |
| SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer. | Int J Mol Sci | 2022 | 35163739 | PubTator, text mining | PubMed |
| Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer. | Int J Mol Sci | 2022 | 35163550 | PubTator, text mining | PubMed |
| Estrogens-Origin of Centrosome Defects in Human Cancer? | Cells | 2022 | 35159242 | PubTator, text mining | PubMed |
| Bronchial Carcinoids: From Molecular Background to Treatment Approach. | Cancers (Basel) | 2022 | 35158788 | PubTator, text mining | PubMed |
| The Role of Mitotic Kinases and the RZZ Complex in Kinetochore-Microtubule Attachments: Doing the Right Link. | Front Cell Dev Biol | 2022 | 35155423 | PubTator, text mining | PubMed |
| Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature. | PLoS One | 2022 | 35143511 | PubTator, text mining | PubMed |
| Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35141281 | PubTator, text mining | PubMed |
| Prediction of New Risk Genes and Potential Drugs for Rheumatoid Arthritis from Multiomics Data. | Comput Math Methods Med | 2022 | 35140805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=40